India: ABD invests US$10m in PPP dialysis group

The Asian Development Bank (ADB) will invest US$10m in DCDC Healthcare Services (DCDC), India’s largest operator of public-private partnership (PPP) dialysis centres, to increase the company’s capacity to provide renal treatment services in India.

The ADB investment will be placed in equivalent Indian rupees and includes a US$5m equity investment made on behalf of Leading Asia’s Private Infrastructure Fund (LEAP), which is supported by the Japan International Cooperation Agency (JICA).

An investment of US$11.5m (in equivalent Indian rupees) is provided by the Danish development finance institution, Investment Fund for Developing Countries (IFU), on behalf of the Danish Sustainable Development Goals Investment Fund which is backed by the Government of Denmark, leading Danish pension funds, and other private and institutional investors.

“The relatively high cost of renal care treatment coupled with travel expenses and scarce dialysis services can damage income and employment prospects especially at low-income households,” said ADB principal investment specialist Samarendra Singh. “ADB and IFU’s combined support aims to ensure DCDC’s continued robust operations and expand its reach in India.”

DCDC is India’s largest operator of public–private partnership (PPP) dialysis centres. Since ADB’s first round of investment in 2018, the company has established 24 new PPP centres in government hospitals. DCDC now has more than 100 centres in public hospitals, private hospitals, and as stand-alone clinics.